Acc Offers Guidance On Using Diabetes Drugs For Cv Event Reduction | Latest News RSS feed

Acc Offers Guidance On Using Diabetes Drugs For Cv Event Reduction - Latest News


Diabetes drug effective against heart failure in wide spectrum of patients

New Orleans, LA (Mar 18, 2019) - The cardiovascular benefits of the diabetes drug dapagliflozin extend ... a significantly greater reduction than the 12 percent drop in the likelihood of these events ... read more

Duke Study to Examine How Diabetes, Cardiovascular Guidelines Get Into Clinical Practice

The COORDINATE-Diabetes seeks to explore what happens between development of clinical guidelines ... cardiovascular indications from FDA; in addiction the GLP-1 receptor agonist liraglutide has an FDA ... read more

For 2019, ADA and ACC Align Their Diabetes Recommendations

For the first time in its annual diabetes management guidelines, the American Diabetes Association (ADA) has aligned its recommendations with those of the American College of Cardiology (ACC) for ... read more

Looking for another news?


AHA/ACC Issue New Cholesterol Management Guideline

published as a companion to the cholesterol guideline offers a more detailed explanation of the use of quantitative risk assessment in primary prevention for cardiovascular disease. The risk ... read more


Managing Dyslipidemia to Reduce Cardiovascular Risk in Adults With Diabetes

4,5 The recent 2018 AHA/ACC Multi-Society Cholesterol Guidelines recommend that all adults with diabetes ages 40-75 with an LDL-C >70 should receive a moderate or high intensity statin. Additionally, ... read more

Updated cholesterol guidelines offer more personalized risk assessment, additional treatment options for people at the highest risk

A special report simultaneously published as a companion to the cholesterol guidelines provides a more detailed perspective about the use of ... and offers cardiovascular accreditation to hospitals ... read more

Pure omega-3 prescription drug markedly reduces first, repeat and total CV events

Earlier analyses of the Reduction of Cardiovascular Events with ... of an impact the drug is having on these patients over time, especially in the context of patients who are already well treated with ... read more

New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients

The United States Preventive Services Task Force (USPSTF) has issued new guidelines on the use ... cardiovascular risk factor and a 10-year event risk of 10% of greater (B recommendation). In addition ... read more

DECLARE: Dapagliflozin Offers Benefits for Diabetes Patients With Heart Failure

New findings for the type 2 diabetes (T2D) drug dapagliflozin show it offers ... (ACC) meeting in New Orleans, Louisiana. On Sunday, ACC and leaders from the American Heart Association released ... read more

2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention

In patients with diabetes ... the guidelines offer 3 steps in selection of statin therapy. A patient-clinician risk discussion is necessary at each of the steps. The first step is to estimate 10-year ... read more

Living with High Cholesterol

The researchers quantified health gains using quality-adjusted life-years. “We found that the risk threshold used in the current ACC/AHA guidelines (above ... percent of patients at high risk for ... read more

Not All Fish Oils Are Created Equal: an ACC Expert Analysis

Data from the randomized controlled Reduction of Cardiovascular Events with ... new cholesterol guidelines. Am Heart J 2016;182:97-102. 30. Pokharel Y, Gosch K, Nambi V, et al. Practice-Level ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us